| MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression … S Hu, ZY Xu-Monette, A Tzankov, T Green, L Wu, A Balasubramanyam, ... Blood, The Journal of the American Society of Hematology 121 (20), 4021-4031, 2013 | 819 | 2013 |
| Oligonucleotide aptamers: new tools for targeted cancer therapy H Sun, X Zhu, PY Lu, RR Rosato, W Tan, Y Zu Molecular Therapy-Nucleic Acids 3, 2014 | 619 | 2014 |
| Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins CM Bollard, S Gottschalk, V Torrano, O Diouf, S Ku, Y Hazrat, G Carrum, ... Journal of Clinical Oncology 32 (8), 798-808, 2014 | 533 | 2014 |
| p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation YL Zu, J Qi, A Gilchrist, GA Fernandez, D Vazquez-Abad, DL Kreutzer, ... The Journal of Immunology 160 (4), 1982-1989, 1998 | 445 | 1998 |
| Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large … C Visco, Y Li, ZY Xu-Monette, RN Miranda, TM Green, A Tzankov, W Wen, ... Leukemia 26 (9), 2103-2113, 2012 | 410 | 2012 |
| Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP … ZY Xu-Monette, L Wu, C Visco, YC Tai, A Tzankov, W Liu, ... Blood, The Journal of the American Society of Hematology 120 (19), 3986-3996, 2012 | 402 | 2012 |
| Detecting circulating tumor cells: current challenges and new trends B Hong, Y Zu Theranostics 3 (6), 377, 2013 | 381 | 2013 |
| A highlight of recent advances in aptamer technology and its application H Sun, Y Zu Molecules 20 (7), 11959-11980, 2015 | 347 | 2015 |
| CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation X Han, Z Liu, MC Jo, K Zhang, Y Li, Z Zeng, N Li, Y Zu, L Qin Science advances 1 (7), e1500454, 2015 | 321 | 2015 |
| Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts N Maulik, M Watanabe, YL Zu, CK Huang, GA Cordis, JA Schley, DK Das FEBS letters 396 (2-3), 233-237, 1996 | 308 | 1996 |
| CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL … S Hu, ZY Xu-Monette, A Balasubramanyam, GC Manyam, C Visco, ... Blood, The Journal of the American Society of Hematology 121 (14), 2715-2724, 2013 | 283 | 2013 |
| Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2 N Maulik, T Yoshida, YL Zu, M Sato, A Banerjee, DK Das American Journal of Physiology-Heart and Circulatory Physiology 275 (5 …, 1998 | 231 | 1998 |
| Multiplexed volumetric bar-chart chip for point-of-care diagnostics Y Song, Y Zhang, PE Bernard, JM Reuben, NT Ueno, RB Arlinghaus, ... Nature communications 3 (1), 1283, 2012 | 218 | 2012 |
| Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International … C Visco, A Tzankov, ZY Xu-Monette, RN Miranda, YC Tai, Y Li, W Liu, ... Haematologica 98 (2), 255, 2013 | 197 | 2013 |
| Human T cell L-plastin bundles actin filaments in a calcium dependent manner Y Namba, M Ito, Y Zu, K Shigesada, K Maruyama The Journal of Biochemistry 112 (4), 503-507, 1992 | 179 | 1992 |
| Medicinal chemistry of paclitaxel and its analogues Y Fu, S Li, Y Zu, G Yang, Z Yang, M Luo, S Jiang, M Wink, T Efferth Current medicinal chemistry 16 (30), 3966-3985, 2009 | 169 | 2009 |
| Tumor-specific T-cells engineered to overcome tumor immune evasion induce clinical responses in patients with relapsed Hodgkin lymphoma CM Bollard, T Tripic, CR Cruz, G Dotti, S Gottschalk, V Torrano, ... Journal of clinical oncology 36 (11), 1128-1139, 2018 | 167 | 2018 |
| Aptamers and their applications in nanomedicine H Sun, Y Zu Small 11 (20), 2352-2364, 2015 | 167 | 2015 |
| Prevalence and Clinical Implications of Epstein–Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries CY Ok, L Li, ZY Xu-Monette, C Visco, A Tzankov, GC Manyam, ... Clinical Cancer Research 20 (9), 2338-2349, 2014 | 158 | 2014 |
| Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma Q Ye, ZY Xu-Monette, A Tzankov, L Deng, X Wang, GC Manyam, C Visco, ... Oncotarget 7 (3), 2401, 2016 | 128 | 2016 |
